Shanghai MicroPort Endovascular MedTech Co., Ltd. (SHA:688016)
China · Delayed Price · Currency is CNY 93.46
-0.44 (-0.47%)
Aug 4, 2026, 3:00 PM CST
SHA:688016 Market Cap
SHA:688016 has a market cap or net worth of 11.35 billion as of August 4, 2026. Its market cap has decreased by -14.73% in one year.
Market Cap
11.35B
Enterprise Value
9.30B
Revenue
1.39B
Ranking
n/a
PE Ratio
19.23
Stock Price
93.46
ChartMarket Cap Chart
Since July 22, 2019, SHA:688016's market cap has decreased from 11.39B to 11.35B, a decrease of -0.41%. That is a compound annual growth rate of -0.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 11.35B | 2.38% |
| Dec 31, 2025 | 11.08B | -17.55% |
| Dec 31, 2024 | 13.44B | -16.51% |
| Dec 29, 2023 | 16.10B | 18.33% |
| Dec 30, 2022 | 13.61B | -24.00% |
| Dec 31, 2021 | 17.90B | -0.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 22, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jafron Biomedical | 14.40B |
| Shandong Weigao Blood Purification Products | 13.45B |
| MeHow Innovative | 12.51B |
| Cofoe Medical Technology | 11.76B |
| Beijing Balance Medical Technology | 11.52B |
| Shanghai MicroPort EP MedTech | 9.32B |
| Sinocare | 9.05B |
| Qingdao Haier Biomedical Co.,Ltd | 8.80B |